glp 1 drug interactions Tirzepatide (Mounjaro) GLP-1 Agonist-Induced Delayed Gastric Emptying

GLP-1 medications such as Ozempic and Wegovy have significantly reshaped the weight loss market by improving blood sugar regulation, insulin sensitivity, and appetite control

A recent article by Paggers et al

and increased insulin early AUC and C-peptide total and early AUCs

The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period

Method The PubMed (MEDLINE), EMBASE, Cochrane Library, and ClinicalTrials.gov databases were searched from the establishment of the database to December 24, 2022

Explore the implications of proposed changes to GLP-1 medication coverage and their impact on Medicare and Medicaid health plans